Biofil Chemicals & Pharmaceuticals (NSE:BIOFILCHEM) EV-to-FCF: (As of Jul. 24, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:BIOFILCHEM Biofil Chemicals & Pharmaceuticals Ltd NSE:BIOFILCHEM
73 GF Score
Price ₹32.07
GF Value ₹41.63
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Biofil Chemicals & Pharmaceuticals EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Biofil Chemicals & Pharmaceuticals's Enterprise Value is ₹517.4 Mil. Biofil Chemicals & Pharmaceuticals's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.0 Mil. Therefore, Biofil Chemicals & Pharmaceuticals's EV-to-FCF for today is .

The historical rank and industry rank for Biofil Chemicals & Pharmaceuticals's EV-to-FCF or its related term are showing as below:

NSE:BIOFILCHEM' s EV-to-FCF Range Over the Past 10 Years
Min: -66.91   Med: 0   Max: 0
Current: -66.91
NSE:BIOFILCHEM's EV-to-FCF is ranked worse than
100% of 568 companies
in the Drug Manufacturers industry
Industry Median: 21.015 vs NSE:BIOFILCHEM: -66.91

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-07-24), Biofil Chemicals & Pharmaceuticals's stock price is ₹32.07. Biofil Chemicals & Pharmaceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹1.580. Therefore, Biofil Chemicals & Pharmaceuticals's PE Ratio (TTM) for today is 20.30.

Biofil Chemicals & Pharmaceuticals  (NSE:BIOFILCHEM) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Biofil Chemicals & Pharmaceuticals's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=32.07/1.580
=20.30

Biofil Chemicals & Pharmaceuticals's share price for today is ₹32.07.
Biofil Chemicals & Pharmaceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1.580.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Biofil Chemicals & Pharmaceuticals EV-to-FCF Related Terms

Biofil Chemicals & Pharmaceuticals EV-to-FCF Historical Data

* Premium members only.

The historical data trend for Biofil Chemicals & Pharmaceuticals's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biofil Chemicals & Pharmaceuticals EV-to-FCF Chart

Biofil Chemicals & Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -325.68 -554.94 40.66 -33.18 -51.91

Biofil Chemicals & Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -33.18 0.00 0.00 0.00 -51.91

NSE:BIOFILCHEM vs ZTS, UTHR: EV-to-FCF Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Biofil Chemicals & Pharmaceuticals's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biofil Chemicals & Pharmaceuticals EV-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biofil Chemicals & Pharmaceuticals's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Biofil Chemicals & Pharmaceuticals's EV-to-FCF falls into.


NSE:BIOFILCHEM
73GF Score
Biofil Chemicals & Pharmaceuticals Ltd NSE:BIOFILCHEM
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biofil Chemicals & Pharmaceuticals EV-to-FCF Calculation

Biofil Chemicals & Pharmaceuticals's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=517.372/0
=

Biofil Chemicals & Pharmaceuticals's current Enterprise Value is ₹517.4 Mil.
Biofil Chemicals & Pharmaceuticals's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Biofil Chemicals & Pharmaceuticals (NSE:BIOFILCHEM) Overvalued in 2026?

Based on GuruFocus' analysis, Biofil Chemicals & Pharmaceuticals stock appears to be undervalued. The current stock price of ₹32.07 is trading 23% below its estimated GF Value™ of ₹41.63. GuruFocus considers Biofil Chemicals & Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for NSE:BIOFILCHEM:

  • EV-to-FCF:
  • GF Value™: ₹41.63 vs. price of ₹32.07 (23% below fair value)
  • GF Score™: 73/100 with 7 warning signs

No single metric tells the full story. See the NSE:BIOFILCHEM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biofil Chemicals & Pharmaceuticals Business Description

Other Exchanges 524396:India
Address 11/12, Sector E Sanwer Road, Industrial Area, Indore, MP, IND, 452015
Biofil Chemicals & Pharmaceuticals Ltd is an Indian pharmaceutical company. It deals in the manufacturing and trading of pharmaceuticals. Further, the company also deals in providing job work facilities with respect to the manufacturing of pharmaceutical drugs. Its product portfolio comprises basic drugs and pharmaceuticals such as sodium citrate, sodium chloride, ferrous sulphate, micro crystalline cellulose, dicyclomine hydrochloride, and others. The company's operating segments are: Pharma, which derives maximum revenue, and Chemicals. Geographically, it caters to both domestic and international markets.
73GF Score

Get the complete analysis for NSE:BIOFILCHEM

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹32.07
Price
₹41.63
GF Value